In our study, we found that QPCT bound to HRAS and increased the stability of HRAS by reducing its ubiquitination degradation, thus activating the ERK signalling pathway and leading to sunitinib resistance in RCC. The gene discussed is HRAS; the disease is renal cell carcinoma.